TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
about
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
TLK286 (Telcyta) in Combinatio ...... ry or Resistant Ovarian Cancer
@en
type
label
TLK286 (Telcyta) in Combinatio ...... ry or Resistant Ovarian Cancer
@en
prefLabel
TLK286 (Telcyta) in Combinatio ...... ry or Resistant Ovarian Cancer
@en
P4844
P6153
P1476
Phase III Randomized Study of ...... tant Ovarian Cancer [ASSIST-3]
@en
P3098
NCT00102973
P580
2004-12-01T00:00:00Z
P582
2008-07-01T00:00:00Z